Tumor targeting using liposomal antineoplastic drugs

References

• AdvaniRSabaHITallmanMSTreatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC 833 (Valspodar)Blood199993787959920827
   PubMed Web of Science ®Google Scholar
• AllenTMLong-circulating (sterically stabilized) liposomes for targeted drug deliveryTrends Pharmacol Sci199415215207940982
   PubMed Web of Science ®Google Scholar
• AllenTMBrandeisEHansenCBA new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cellsBiochim Biophys Acta19951237991087632714
   PubMed Web of Science ®Google Scholar
• AllenTMChonnALarge unilamellar liposomes with low uptake into the reticuloendothelial systemFEBS Lett19872234263666140
   PubMed Web of Science ®Google Scholar
• AnabousiSBakowskyUSchneiderMIn vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancerEur J Pharm Sci2006293677416952451
   PubMed Web of Science ®Google Scholar
• BaileyALAntibody-directed enzyme prodrug therapy (Adept)J Control Release19942818793
   Web of Science ®Google Scholar
• BaselgaJClinical trials of single-agent trastuzumab (Herceptin)Semin Oncol20002720611049053
   PubMed Web of Science ®Google Scholar
• BlumeGCevcGCrommelinMDSpecific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation timesBiochim Biophys Acta1993114918048318529
   PubMed Web of Science ®Google Scholar
• BoeschDGavériauxCJachezBIn vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833Cancer Res1991514226331678313
   PubMed Web of Science ®Google Scholar
• CerlettiADreweJFrickerGEndocytosis and transcytosis of an immunoliposome-based brain drug delivery systemJ Drug Targeting2000843547
   PubMed Web of Science ®Google Scholar
• ConnorJHuangLpH-sensitive immunoliposomes as an efficient and target-specific carrier for antitumor drugsCancer Res198646343152871923
   PubMed Web of Science ®Google Scholar
• DaemenTActivation of Kupffer cell tumoricidal activity by immunomodulators encapsulated in liposomesRes Immunol199214321141574650
   PubMedGoogle Scholar
• DaemenTHofstedeGTen KateMTLiposomal doxorubicin-induced toxicity: depletion and impairment of phagocytic activity of liver macrophagesInt J Cancer199561716217768646
   PubMed Web of Science ®Google Scholar
• DeryckeAKamuhabwaAGijsensATransferrin-conjugated liposome targeting of the photosensitizer AlPcS4 to rat bladder carcinoma cellsJournal of the National Cancer Institute20049616203015523091
   PubMed Web of Science ®Google Scholar
• DrummondDCZignaniMLerouxJCurrent status of pH-sensitive liposomes in drug deliveryProg Lipid Res2000394096011082506
   PubMed Web of Science ®Google Scholar
• EfferthTOsiekaRClinical relevance of the MDR-1 gene and its gene product, P-glycoprotein, for cancer chemotherapy: a meta-analysisTumordiagn u Ther19931423843
   Web of Science ®Google Scholar
• EwerMSMartinFJHendersonCCardiac safety of liposomal anthracyclinesSemin Oncol2004311618115717742
   PubMed Web of Science ®Google Scholar
• FlynnJMByrdJCCampath-1H monoclonal antibody therapyCurr Opin Oncol2000125748111085457
   PubMed Web of Science ®Google Scholar
• FonsecaMJJagtenbergJCHaismaHJLiposome-mediated targeting of enzymes to cancer cells for site-specific activation of pro-drugs: comparison with the corresponding antibody-enzyme conjugatePharm Res200320423812669963
   PubMed Web of Science ®Google Scholar
• FrankMMThe reticuloendothelial system and bloodstream clearanceJ Lab Clin Med199312248788228564
   PubMed Web of Science ®Google Scholar
• FridenPMWalusLRMussoGFAnti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrierProc Natl Acad Sci USA199188477152052557
   PubMed Web of Science ®Google Scholar
• GabizonACataneRUzielyBProlonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomesCancer Res199454987928313389
   PubMed Web of Science ®Google Scholar
• GabizonAPapahadjopoulosDThe role of surface charge and hydrophilic groups on liposome clearance in vivoBiochim Biophys Acta19921103941001309663
   PubMed Web of Science ®Google Scholar
• GabizonAShmeedaHBarenholzYPharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studiesClin Pharmacokinet2003424193612739982
   PubMed Web of Science ®Google Scholar
• GabizonAShmeedaHHorowitzATTumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugatesAdv Drug Deliv Rev20045611779215094214
   PubMed Web of Science ®Google Scholar
• GabizonAAPegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapyCancer Invest2001194243611405181
   PubMed Web of Science ®Google Scholar
• GabizonAAShmeedaHZalipskySPros and cons of the liposome platform in cancer drug targetingJ Liposome Res2006161758316952872
   PubMed Web of Science ®Google Scholar
• GijsenADeryckeAMissiaenLTargeting of the phototoxic compound AIPcS4 to HeLa cells by transferrin conjugated PEG-liposomesInt J Cancer2002101788512209592
   PubMed Web of Science ®Google Scholar
• GosselinMALeeRJFolate receptor-targeted liposomes as vectors for therapeutic agentsBiotechnol Annu Rev200281033112436917
   PubMedGoogle Scholar
• GulatiMBajadSSinghSDevelopment of liposomal amphotericin B formulationJ Microencapsul199815137519532520
   PubMed Web of Science ®Google Scholar
• HamiltonABiganzoliLColemanREORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx, Doxil) at a 6-week interval in patients with metastatic breast cancer. European Organization for Research and Treatment of CancerAnn Oncol200213910812123337
   PubMed Web of Science ®Google Scholar
• HansenCBKaoGYMoaseEHAttachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling proceduresBiochim Biophys Acta19951239133447488618
   PubMed Web of Science ®Google Scholar
• HilgenbrinkARLowPSFolate receptor-mediated drug targeting: from therapeutics to diagnosticsJ Pharm Sci20059421354616136558
   PubMed Web of Science ®Google Scholar
• HofheinzRDGnad-VogtSUBeyerULiposomal encapsulated anti-cancer drugsAnticancer Drugs20051669170716027517
   PubMed Web of Science ®Google Scholar
• HosokawaSTagawaTNikiHEfficacy of immunoliposomes on cancer models in a cell-surface-antigen-density-dependent mannerBr J Cancer20038915455114562030
   PubMed Web of Science ®Google Scholar
• HuwylerJCerlettiAFrickerGBy-passing of P-glycoprotein using immunoliposomesJ Drug Targeting200210739
   PubMed Web of Science ®Google Scholar
• HuwylerJWuDPardridgeWMBrain drug delivery of small molecules using immunoliposomesProc Natl Acad Sci USA1996931416498943078
   PubMed Web of Science ®Google Scholar
• ImaiKTakaokaAComparing antibody and small-molecule therapies for cancerNat Rev Cancer200667142716929325
   PubMed Web of Science ®Google Scholar
• IshidaOMaruyamaKTanahashiHLiposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivoPharm Res2001181042811496943
   PubMed Web of Science ®Google Scholar
• ItoAShinkaiMHondaHMedical application of functionalized magnetic nanoparticlesJ Biosci Bioeng200510011116233845
   PubMed Web of Science ®Google Scholar
• JulianoRLLingVA surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsBiochim Biophys Acta197645515262990323
   PubMed Web of Science ®Google Scholar
• JulianoRLStampDPharmacokinetics of liposome-encapsulated anti-tumor drugs. Studies with vinblastine, actinomycin D, cytosine arabinoside, and daunomycinBioch Pharmacol197827217
   PubMed Web of Science ®Google Scholar
• KanwarYSLiuZZKashiharaNCurrent status of the structural and functional basis of glomerular filtration and proteinuriaSemin Nephrol1991113904131947494
   PubMed Web of Science ®Google Scholar
• KirpotinDParkJWHongKSterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitroBiochemistry19973666758993319
   PubMed Web of Science ®Google Scholar
• KleinISarkadiBVaradiAAn inventory of the human ABC proteinsBiochim Biophys Acta199914612376210581359
   PubMed Web of Science ®Google Scholar
• KlibanovALMaruyamaKTorchilinVPAmphipathic polyethyleneglycols effectively prolong the circulation time of liposomesFEBS Lett199026823572384160
   PubMed Web of Science ®Google Scholar
• KrishnaRMayerLDThe use of liposomal anticancer agents to determine the roles of drug pharmacodistribution and P-glycoprotein (PGP) blockade in overcoming multidrug resistance (MDR)Anticancer Res19991928859110652569
   PubMed Web of Science ®Google Scholar
• LasicDDDoxorubicin in sterically stabilized liposomesNature199638056128606781
   PubMed Web of Science ®Google Scholar
• LasicDDPapahadjopoulosDLiposomes revisitedScience1995267127567871422
   PubMed Web of Science ®Google Scholar
• LemaireMBruelisauerAGuntzPDose-dependent brain penetration of SDZ PSC 833, a novel multidrug resistance-reversing cyclosporin, in ratsCancer Chemother Pharmacol19963848168765444
   PubMed Web of Science ®Google Scholar
• LitmanTDruleyTESteinWDFrom MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significanceCell Mol Life Sci2001589315911497241
   PubMed Web of Science ®Google Scholar
• LiuYLiggittDZhongWCationic liposome-mediated intravenous gene deliveryJ Biol Chem199527024864707559609
   PubMed Web of Science ®Google Scholar
• LiuYMounkesLCLiggittHDFactors influencing the efficiency of cationic liposome-mediated intravenous gene deliveryNat Biotechnol199715167739035144
   PubMed Web of Science ®Google Scholar
• LoboEDHansenRJBalthasarJPAntibody pharmacokinetics and pharmacodynamicsJ Pharm Sci20049326456815389672
   PubMed Web of Science ®Google Scholar
• MaedaHThe enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targetingAdv Enzyme Regul20014118920711384745
   PubMedGoogle Scholar
• MaedaHWuJSawaTTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release2000652718410699287
   PubMed Web of Science ®Google Scholar
• MamotCDrummondDCHongKLiposome-based approaches to overcome anticancer drug resistanceDrug Resist Updates200362719
   PubMed Web of Science ®Google Scholar
• MastrobattistaEKoningGAStormGImmunoliposomes for the targeted delivery of antitumor drugsAdv Drug Deliv Rev1999401032710837783
   PubMed Web of Science ®Google Scholar
• MatsumuraYGotohMMuroKPhase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancerAnn Oncol2004155172514998859
   PubMed Web of Science ®Google Scholar
• MatsuoHWakasugiMTakanagaHPossibility of the reversal of multidrug resistance and the avoidance of side effects by liposomes modified with MRK-16, a monoclonal antibody to P-glycoproteinJ Control Release200177778611689261
   PubMed Web of Science ®Google Scholar
• McLaughlinPGrillo-LopezAJLinkBKRituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment programJ Clin Oncol1998162825339704735
   PubMed Web of Science ®Google Scholar
• MizunoNSugiyamaYDrug transporters: their role and importance in the selection and development of new drugsDrug Metab Pharmacokinet2002179310815618657
   PubMedGoogle Scholar
• MoghimiSMPatelHMOpsonophagocytosis of liposomes by peritoneal macrophages and bone marrow reticuloendothelial cellsBiochim Biophys Acta19921135269741623013
   PubMed Web of Science ®Google Scholar
• MrossKNiemannBMassingUPharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose studyCancer Chemother Pharmacol200454514512415322827
   PubMed Web of Science ®Google Scholar
• OsakaGCareyKCuthbertsonAPharmacokinetics, tissue distribution, and expression efficiency of plasmid [33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approachJ Pharm Sci19968561288773958
   PubMed Web of Science ®Google Scholar
• PanXQLeeRJIn vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia modelAnticancer Res200525343615816557
   PubMed Web of Science ®Google Scholar
• PapahadjopoulosDAllenTMGabizonASterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacyProc Natl Acad Sci USA1991881146041763060
   PubMed Web of Science ®Google Scholar
• PardridgeWMBrain drug delivery and blood-brain barrier transportDrug Delivery1993183101
   Google Scholar
• ParkJWBenzCCMartinFJFuture directions of liposome- and immunoliposome-based cancer therapeuticsSemin Oncol20043119620515717745
   PubMed Web of Science ®Google Scholar
• ParkJWHongKKirpotinDBAnti-HER2 immunoliposomes: enhanced efficacy attributable to targeted deliveryClin Cancer Res2002811728111948130
   PubMed Web of Science ®Google Scholar
• ParkJWKirpotinDBHongKTumor targeting using anti-her2 immunoliposomesJ Control Release2001749511311489487
   PubMed Web of Science ®Google Scholar
• PastanIIKreitmanRJImmunotoxins for targeted cancer therapyAdv Drug Deliv Rev199831538810837618
   PubMed Web of Science ®Google Scholar
• PhotosPJBacakovaLDischerBPolymer vesicles in vivo: correlations with PEG molecular weightJ Control Release2003903233412880699
   PubMed Web of Science ®Google Scholar
• RädlerJOKoltoverISaldittTStructure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimesScience199727581049012343
   PubMed Web of Science ®Google Scholar
• SchinkelAHJonkerJWMammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overviewAdv Drug Deliv Rev20035532912535572
   PubMed Web of Science ®Google Scholar
• SchnellRBorchmannPStaakJOClinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin’s lymphomaAnn Oncol2003147293612702527
   PubMed Web of Science ®Google Scholar
• SchnyderAHuwylerJDrug transport to brain with targeted liposomesNeuroRx200529910715717061
   PubMedGoogle Scholar
• ShahinianSSilviusJRA novel strategy affords high-yield coupling of antibody Fab’ fragments to liposomesBiochim Biophys Acta19951239157677488620
   PubMed Web of Science ®Google Scholar
• ShiNPardridgeWMNoninvasive gene targeting to the brainProc Natl Acad Sci USA20009775677210840060
   PubMed Web of Science ®Google Scholar
• ShmeedaHMakLTzemachDIntracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptorsMol Cancer Ther200658182416648551
   PubMed Web of Science ®Google Scholar
• SikicBIPharmacologic approaches to reversing multidrug resistanceSemin Hematol1997344079408960
   PubMed Web of Science ®Google Scholar
• SinkuleJARosenSTRadosevichJAMonoclonal antibody 44-3A6 doxorubicin immunoconjugates: comparative in vitro anti-tumor effi-cacy of different conjugation methodsTumour Biol1991121982061651554
   PubMedGoogle Scholar
• SkarlatosSYoshikawaTPardridgeWMTransport of [125I]transferrin through the rat blood-brain barrierBrain Res1995683164717552351
   PubMed Web of Science ®Google Scholar
• SongSSuzukiHKawaiREffect of PSC 833, a P-glycoprotein modulator on the disposition of vincristine and digoxin in ratsDrug Metab Dispos1999276899410348798
   PubMed Web of Science ®Google Scholar
• SpectorMSSchnurJMDNA ordering on a lipid membraneScience199727579129036545
   PubMed Web of Science ®Google Scholar
• StathopoulosGPBoulikasTVougioukaMPharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I studyOncol Rep2005135899515756428
   PubMed Web of Science ®Google Scholar
• StevensPJLeeRJFormulation kit for liposomal doxorubicin composed of lyophilized liposomesAnticancer Res2003234394212680245
   PubMed Web of Science ®Google Scholar
• SuzukiSInoueKHongohAModulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferrin receptorBr J Cancer1997768399218737
   PubMed Web of Science ®Google Scholar
• ThiebautFTsuruoTHamadaHCellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissueProc Natl Acad Sci198784773582444983
   PubMed Web of Science ®Google Scholar
• TorchilinVPRecent advances with liposomes as pharmaceutical carriersNat Rev Drug Discov200541456015688077
   PubMed Web of Science ®Google Scholar
• UsterPSAllenTMDanielBEInsertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation timeFEBS Lett199638624368647291
   PubMed Web of Science ®Google Scholar
• VingerhoedsMHHaismaHJvanMMA new application for liposomes in cancer therapy. Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of prodrugsFEBS Letters1993336485908282116
   PubMed Web of Science ®Google Scholar
• VingerhoedsMHSteerenbergPAHendriksJJImmunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivoBr J Cancer199674102398855969
   PubMed Web of Science ®Google Scholar
• WangSLowPSFolate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cellsJ Control Release19985339489741912
   PubMed Web of Science ®Google Scholar
• WaterhouseDNTardiPGMayerLDA comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profilesDrug Saf2001249032011735647
   PubMedGoogle Scholar
• WongJYKuhlTLIsraelachviliJNDirect measurement of a tethered ligand-receptor interaction potentialScience199727582029012346
   PubMed Web of Science ®Google Scholar
• WoodleMCMatthayKKNewmanMSVersatility in lipid compositions showing prolonged circulation with sterically stabilized liposomesBiochim Biophys Acta199211051932001586658
   PubMed Web of Science ®Google Scholar
• WorthLLJiaSFAnTImmTher, a lipophilic disaccharide derivative of muramyl dipeptide, up-regulates specific monocyte cytokine genes and activates monocyte-mediated tumoricidal activityCancer Immunol Immunother1999483122010473806
   PubMed Web of Science ®Google Scholar
• XuLHuangCCHuangWSystemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomesMol Cancer Ther200213374612489850
   PubMed Web of Science ®Google Scholar
• YuanFDellianMFukumuraDVascular permeability in a human tumor xenograft: molecular size dependence and cutoff sizeCancer Res199555375267641188
   PubMed Web of Science ®Google Scholar
• ZhangYCalonFZhuCIntravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonismHum Gene Ther20031411212573054
   PubMed Web of Science ®Google Scholar
• ZhangYSchlachetzkiFPardridgeWMGlobal non-viral gene transfer to the primate brain following intravenous administrationMol Ther2003711812573613
   PubMed Web of Science ®Google Scholar